190 related articles for article (PubMed ID: 30606694)
1. Network-based approach to identify molecular signatures and therapeutic agents in Alzheimer's disease.
Rahman MR; Islam T; Turanli B; Zaman T; Faruquee HM; Rahman MM; Mollah MNH; Nanda RK; Arga KY; Gov E; Moni MA
Comput Biol Chem; 2019 Feb; 78():431-439. PubMed ID: 30606694
[TBL] [Abstract][Full Text] [Related]
2. Identification of molecular signatures and pathways to identify novel therapeutic targets in Alzheimer's disease: Insights from a systems biomedicine perspective.
Rahman MR; Islam T; Zaman T; Shahjaman M; Karim MR; Huq F; Quinn JMW; Holsinger RMD; Gov E; Moni MA
Genomics; 2020 Mar; 112(2):1290-1299. PubMed ID: 31377428
[TBL] [Abstract][Full Text] [Related]
3. A Network-Based Bioinformatics Approach to Identify Molecular Biomarkers for Type 2 Diabetes that Are Linked to the Progression of Neurological Diseases.
Rahman MH; Peng S; Hu X; Chen C; Rahman MR; Uddin S; Quinn JMW; Moni MA
Int J Environ Res Public Health; 2020 Feb; 17(3):. PubMed ID: 32041280
[TBL] [Abstract][Full Text] [Related]
4. Network-Based Genetic Profiling Reveals Cellular Pathway Differences Between Follicular Thyroid Carcinoma and Follicular Thyroid Adenoma.
Hossain MA; Asa TA; Rahman MM; Uddin S; Moustafa AA; Quinn JMW; Moni MA
Int J Environ Res Public Health; 2020 Feb; 17(4):. PubMed ID: 32093341
[TBL] [Abstract][Full Text] [Related]
5. Genome-Wide Profiling of miRNA and mRNA Expression in Alzheimer's Disease.
Chang WS; Wang YH; Zhu XT; Wu CJ
Med Sci Monit; 2017 Jun; 23():2721-2731. PubMed ID: 28578378
[TBL] [Abstract][Full Text] [Related]
6. Disclosing Potential Key Genes, Therapeutic Targets and Agents for Non-Small Cell Lung Cancer: Evidence from Integrative Bioinformatics Analysis.
Mosharaf MP; Reza MS; Gov E; Mahumud RA; Mollah MNH
Vaccines (Basel); 2022 May; 10(5):. PubMed ID: 35632527
[TBL] [Abstract][Full Text] [Related]
7. Identification of host transcriptome-guided repurposable drugs for SARS-CoV-1 infections and their validation with SARS-CoV-2 infections by using the integrated bioinformatics approaches.
Ahmed FF; Reza MS; Sarker MS; Islam MS; Mosharaf MP; Hasan S; Mollah MNH
PLoS One; 2022; 17(4):e0266124. PubMed ID: 35390032
[TBL] [Abstract][Full Text] [Related]
8. Molecular Characterization and Elucidation of Pathways to Identify Novel Therapeutic Targets in Pulmonary Arterial Hypertension.
Yao X; Jing T; Wang T; Gu C; Chen X; Chen F; Feng H; Zhao H; Chen D; Ma W
Front Physiol; 2021; 12():694702. PubMed ID: 34366885
[No Abstract] [Full Text] [Related]
9. Bioinformatics screening of colorectal-cancer causing molecular signatures through gene expression profiles to discover therapeutic targets and candidate agents.
Horaira MA; Islam MA; Kibria MK; Alam MJ; Kabir SR; Mollah MNH
BMC Med Genomics; 2023 Mar; 16(1):64. PubMed ID: 36991484
[TBL] [Abstract][Full Text] [Related]
10. miR-129-5p as a biomarker for pathology and cognitive decline in Alzheimer's disease.
Han SW; Pyun JM; Bice PJ; Bennett DA; Saykin AJ; Kim SY; Park YH; Nho K
Alzheimers Res Ther; 2024 Jan; 16(1):5. PubMed ID: 38195609
[TBL] [Abstract][Full Text] [Related]
11. Exploration of key drug target proteins highlighting their related regulatory molecules, functional pathways and drug candidates associated with delirium: evidence from meta-data analyses.
Mosharaf MP; Alam K; Gow J; Mahumud RA
BMC Geriatr; 2023 Nov; 23(1):767. PubMed ID: 37993790
[TBL] [Abstract][Full Text] [Related]
12. Detection of molecular signatures and pathways shared in inflammatory bowel disease and colorectal cancer: A bioinformatics and systems biology approach.
Al-Mustanjid M; Mahmud SMH; Royel MRI; Rahman MH; Islam T; Rahman MR; Moni MA
Genomics; 2020 Sep; 112(5):3416-3426. PubMed ID: 32535071
[TBL] [Abstract][Full Text] [Related]
13. Serum microRNA miR-501-3p as a potential biomarker related to the progression of Alzheimer's disease.
Hara N; Kikuchi M; Miyashita A; Hatsuta H; Saito Y; Kasuga K; Murayama S; Ikeuchi T; Kuwano R
Acta Neuropathol Commun; 2017 Jan; 5(1):10. PubMed ID: 28137310
[TBL] [Abstract][Full Text] [Related]
14. Exploiting machine learning models to identify novel Alzheimer's disease biomarkers and potential targets.
Alamro H; Thafar MA; Albaradei S; Gojobori T; Essack M; Gao X
Sci Rep; 2023 Mar; 13(1):4979. PubMed ID: 36973386
[TBL] [Abstract][Full Text] [Related]
15. Constructing and characterizing a bioactive small molecule and microRNA association network for Alzheimer's disease.
Meng F; Dai E; Yu X; Zhang Y; Chen X; Liu X; Wang S; Wang L; Jiang W
J R Soc Interface; 2014 Mar; 11(92):20131057. PubMed ID: 24352679
[TBL] [Abstract][Full Text] [Related]
16. A 9-microRNA Signature in Serum Serves as a Noninvasive Biomarker in Early Diagnosis of Alzheimer's Disease.
Guo R; Fan G; Zhang J; Wu C; Du Y; Ye H; Li Z; Wang L; Zhang Z; Zhang L; Zhao Y; Lu Z
J Alzheimers Dis; 2017; 60(4):1365-1377. PubMed ID: 29036818
[TBL] [Abstract][Full Text] [Related]
17. Identification of Molecular Signatures and Candidate Drugs in Vascular Dementia by Bioinformatics Analyses.
Shu J; Wei W; Zhang L
Front Mol Neurosci; 2022; 15():751044. PubMed ID: 35221911
[TBL] [Abstract][Full Text] [Related]
18. Gene biomarker discovery at different stages of Alzheimer using gene co-expression network approach.
Soleimani Zakeri NS; Pashazadeh S; MotieGhader H
Sci Rep; 2020 Jul; 10(1):12210. PubMed ID: 32699331
[TBL] [Abstract][Full Text] [Related]
19. An integrated approach to unravel a putative crosstalk network in Alzheimer's disease and Parkinson's disease.
Bisht I; Ambasta RK; Kumar P
Neuropeptides; 2020 Oct; 83():102078. PubMed ID: 32807513
[TBL] [Abstract][Full Text] [Related]
20. Exploring Potential Biomarkers Underlying the Pathogenesis of Alzheimer's Disease by Bioinformatics Gene Analysis.
Ma X; Meng G; Zhang M; Zhao Y; Zhou Y; Zhao Y; Liu X
Ann Clin Lab Sci; 2021 Mar; 51(2):198-205. PubMed ID: 33941559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
